Select therapeutic use:
Indications for DIPENTUM:
Maintenance of remission in ulcerative colitis in patients intolerant of sulfasalazine.
500mg twice a day with meals.
Monitor urinalysis, BUN, creatinine levels. If diarrhea occurs, monitor serum electrolytes, dehydration status. Pregnancy (Cat.C). Nursing mothers.
Increased prothrombin time with warfarin.
Diarrhea, abdominal pain, rash, pruritus, exacerbation of symptoms of colitis thought to be caused by mesalamine or sulfasalazine.